An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Clinical trial NCT00933205 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00933205
- Sponsor
- Boehringer Ingelheim
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2004-05-01
- Primary completion
- 2008-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.